| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis N Ruperto, HI Brunner, P Quartier, T Constantin, N Wulffraat, G Horneff, ... New England Journal of Medicine 367 (25), 2396-2406, 2012 | 799 | 2012 |
| Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial N Ruperto, DJ Lovell, P Quartier, E Paz, N Rubio-Pérez, CA Silva, ... The Lancet 372 (9636), 383-391, 2008 | 658 | 2008 |
| Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study F Zulian, BH Athreya, R Laxer, AM Nelson, SK Feitosa de Oliveira, ... Rheumatology 45 (5), 614-620, 2006 | 505 | 2006 |
| A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard … N Ruperto, KJ Murray, V Gerloni, N Wulffraat, SK Feitosa De Oliveira, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 473 | 2004 |
| Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial D Foell, N Wulffraat, LR Wedderburn, H Wittkowski, M Frosch, J Gerss, ... Jama 303 (13), 1266-1273, 2010 | 315 | 2010 |
| Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients A Ravelli, L Trail, C Ferrari, N Ruperto, A Pistorio, C Pilkington, S Maillard, ... Arthritis Care & Research: Official Journal of the American College of …, 2010 | 276 | 2010 |
| EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I … N Ruperto, S Ozen, A Pistorio, P Dolezalova, P Brogan, DA Cabral, ... Annals of the rheumatic diseases 69 (5), 790-797, 2010 | 270 | 2010 |
| Juvenile polyarteritis: results of a multicenter survey of 110 children S Ozen, J Anton, N Arisoy, A Bakkaloglu, N Besbas, P Brogan, ... The Journal of pediatrics 145 (4), 517-522, 2004 | 235 | 2004 |
| Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis A Ravelli, GC Varnier, S Oliveira, E Castell, O Arguedas, A Magnani, ... Arthritis & Rheumatism 63 (1), 267-275, 2011 | 233 | 2011 |
| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 228 | 2017 |
| Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial N Ruperto, A Pistorio, S Oliveira, F Zulian, R Cuttica, A Ravelli, ... The Lancet 387 (10019), 671-678, 2016 | 225 | 2016 |
| Proxy‐reported health‐related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality … S Oliveira, A Ravelli, A Pistorio, E Castell, C Malattia, AM Prieur, ... Arthritis Care & Research: Official Journal of the American College of …, 2007 | 174 | 2007 |
| HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis MJ Ombrello, EF Remmers, I Tachmazidou, A Grom, D Foell, JP Haas, ... Proceedings of the National Academy of Sciences 112 (52), 15970-15975, 2015 | 173 | 2015 |
| Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis Y Kimura, JE Weiss, KL Haroldson, T Lee, M Punaro, S Oliveira, ... Arthritis care & research 65 (5), 745-752, 2013 | 173 | 2013 |
| Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications MJ Ombrello, VL Arthur, EF Remmers, A Hinks, I Tachmazidou, AA Grom, ... Annals of the rheumatic diseases 76 (5), 906-913, 2017 | 167 | 2017 |
| Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study A Consolaro, G Giancane, A Alongi, EHP van Dijkhuizen, A Aggarwal, ... The Lancet Child & Adolescent Health 3 (4), 255-263, 2019 | 154 | 2019 |
| Non-clinical studies in the process of new drug development-Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies EL Andrade, AF Bento, J Cavalli, SK Oliveira, RC Schwanke, JM Siqueira, ... Brazilian journal of medical and biological research 49, e5646, 2016 | 154 | 2016 |
| Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes CD Rosé, S Pans, I Casteels, J Anton, B Bader-Meunier, P Brissaud, ... Rheumatology 54 (6), 1008-1016, 2015 | 151 | 2015 |
| The Brazilian version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) CSM Machado, N Ruperto, CHM Silva, VPL Ferriani, I Roscoe, ... Clinical and experimental rheumatology 19 (4; SUPP/23), S25-S29, 2001 | 150 | 2001 |
| Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis S Davì, F Minoia, A Pistorio, AC Horne, A Consolaro, S Rosina, F Bovis, ... Arthritis & rheumatology 66 (10), 2871-2880, 2014 | 132 | 2014 |
Nicolino RupertoIRCCS Istituto G. Gaslini UOC Gaslini Trial Centre/Servizio di Sperimentazioni Cliniche PediatricheVerified email at gaslini.org
